Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes (Scientific Reports, (2019), 9, 1, (18795), 10.1038/s41598-019-55455-6)

Myriam Maoz, Michal Devir, Michal Inbar, Ziva Inbar-Daniel, Dana Sherill-Rofe, Idit Bloch, Karen Meir, David Edelman, Salah Azzam, Hovav Nechushtan, Ofra Maimon, Beatrice Uziely, Luna Kadouri, Amir Sonnenblick, Amir Eden, Tamar Peretz, Aviad Zick*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

A supplementary file containing Tables S1, S2 and S3 was omitted from the original version of this Article. This has been corrected in the HTML version of the Article; the PDF version was correct at time of publication.

Original languageAmerican English
Article number3941
JournalScientific Reports
Volume10
Issue number1
DOIs
StatePublished - 1 Dec 2020

Bibliographical note

Publisher Copyright:
© 2020, The Author(s).

Fingerprint

Dive into the research topics of 'Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes (Scientific Reports, (2019), 9, 1, (18795), 10.1038/s41598-019-55455-6)'. Together they form a unique fingerprint.

Cite this